Back to search

Article

Assessing the Clinical Outcomes of Voxelotor Treatment in Patients with Sickle Cell Disease

2024-03-31

Abstract excerpt

The results of Voxelotor treatment in Sickle Cell Disease, as assessed through clinical outcomes, demonstrated its efficacy in reducing hemolysis and improving hemoglobin levels. This effect can be attributed to Voxelotor's inhibition of HbS polymerization, thereby restoring the deformability and compliance of sickle RBCs. Our mathematical model provided mechanistic insights into how altered rheological properties...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8cddd9eb-93c8-5b75-a3f9-1c1e051d3a72
DOI
10.3126/ijasbt.v12i1.64057
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Assessing the Clinical Outcomes of Voxelotor Treatment in Patients with Sickle Cell DiseaseDOI 10.3126/ijasbt.v12i1.64057
Select a neighboring publication to make it the new centre.